ESC Premium Access

Potential candidates for PCSK9 inhibitors among patients with stable coronary artery disease presumed to be on maximally tolerated hypolipidemic treatment

Topic: Lipids (Epidemiology and Prevention)

Presentation

About the speaker

Professor Loukianos Rallidis

Attikon University Hospital, Athens (Greece)
0 follower

14 more presentations in this session

Associations between very low concentrations of LDL-cholesterol and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) Study

Speaker: Doctor P. Penson (Liverpool, GB)

Thumbnail

Cholesterol efflux capacity and incident atherosclerotic cardiovascular disease events in a Japanese general population

Speaker: Doctor M. Ogura (Suita, JP)

Thumbnail

Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South-Africa, Middle East and China: results of the dyslipidemia international study (dysis)

Speaker: Doctor A. Gitt (Ludwigshafen, DE)

Thumbnail

Comparison of plaque microstructures between two high-intensity statin therapies: rosuvastatin versus atorvastatin

Speaker: Doctor S. Honda (Suita, Osaka, JP)

Thumbnail

Sex-related differences in clinical characteristics, low-density lipoprotein cholesterol control and cardiovascular outcomes in familial hypercholesterolemia.

Speaker: Doctor T. Doi (Herlev, DK)

Thumbnail

Access the full session

Poster session 1 - Lipids

Speakers: Professor L. Rallidis, Doctor P. Penson, Doctor M. Ogura, Doctor A. Gitt, Doctor S. Honda...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk